|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-3-24
|
|
pubmed:abstractText |
The present study prospectively evaluated adjunctive antiplatelet therapy in patients without insulin-requiring diabetes during elective coronary stenting. Three hundred patients were randomized to one of three treatment groups: clopidogrel pretreatment, adjunctive abciximab, or control. Stenting was successful in 98% and no deaths occurred. Thirty-day and 1-year major adverse coronary events (MACEs) was similar in all groups. A subgroup of 109 patients undergoing single-vessel stenting of type A/B1 lesions with short guidewire times had no postprocedure myocardial infarction or 30-day MACE. We conclude that patients with these characteristics may safely undergo elective coronary stenting without adjunctive antiplatelet therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1522-1946
|
|
pubmed:author |
pubmed-author:BowenJosieJ,
pubmed-author:CubedduGabrielaG,
pubmed-author:CubedduRoberto JRJ,
pubmed-author:JobeRobert LeeRL,
pubmed-author:MannTiftT,
pubmed-author:NewmanWilliamW,
pubmed-author:RaynorLauraL,
pubmed-author:RazaJaffar AliJA,
pubmed-author:RoseGregoryG,
pubmed-author:SchneiderJoel EJE,
pubmed-author:ZellingerMichealM
|
|
pubmed:copyrightInfo |
Copyright 2003 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
459-66
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12652495-Aged,
pubmed-meshheading:12652495-Angioplasty, Balloon, Coronary,
pubmed-meshheading:12652495-Antibodies, Monoclonal,
pubmed-meshheading:12652495-Chemotherapy, Adjuvant,
pubmed-meshheading:12652495-Combined Modality Therapy,
pubmed-meshheading:12652495-Coronary Angiography,
pubmed-meshheading:12652495-Coronary Disease,
pubmed-meshheading:12652495-Diabetes Mellitus, Type 1,
pubmed-meshheading:12652495-Diabetic Angiopathies,
pubmed-meshheading:12652495-Female,
pubmed-meshheading:12652495-Follow-Up Studies,
pubmed-meshheading:12652495-Humans,
pubmed-meshheading:12652495-Immunoglobulin Fab Fragments,
pubmed-meshheading:12652495-Male,
pubmed-meshheading:12652495-Probability,
pubmed-meshheading:12652495-Prospective Studies,
pubmed-meshheading:12652495-Reference Values,
pubmed-meshheading:12652495-Risk Assessment,
pubmed-meshheading:12652495-Severity of Illness Index,
pubmed-meshheading:12652495-Stents,
pubmed-meshheading:12652495-Survival Analysis,
pubmed-meshheading:12652495-Ticlopidine,
pubmed-meshheading:12652495-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Coronary stenting in stable patients: identification of a low-risk subgroup that may not require adjunctive antiplatelet therapy.
|
|
pubmed:affiliation |
Wake Heart Center, Raleigh, North Carolina 27610, USA. wakeheartresearch@msn.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
